ABOUT US 
BioTest is a GLP-certified Contract Research Organization dealing with:
- preclinical research and development
- comprehensive toxicological program
- breeding of laboratory animals
BioTest, founder member of CzechBio, the Association of Czech Biotech Companies and member of MedChemBio Cluster, was founded in November 1999 on the basis of Research Institute for Pharmacy and Biochemistry.
BioTest is a private, independent CRO dedicated to preclinical research and development in the field of oncology, cardiovascular disorders, diabetes and antiviral vaccines development including comprehensive safety assessment of human and veterinary pharmaceuticals/biopharmaceuticals, chemicals, agrochemicals and food additives. Emphasis is placed on strongly individual approach, confidentiality, flexibility, competitive pricing, extensive support and to establishing of good relationship with the partners.
BioTest toxicologists have experience in variety of compounds and therapeutic areas. The expert team is capable to conduct a number of experiments in full compliance to GLP standards and in compliance to variuos international guidelines (ICH/VICH, OECD,US FDA, US EPA and other).
BioTest scientific activities are concentrated to the area of anti-influenza vaccines, oncology, diabetology and cardiovascular disorders. Participation in EU grants projects (the 6th and 7th Frame Program) is essential.
BioTest location in a small village but in close connection to all types of transport gives us an ideal possibility to associate challenging work with pleasant work place and atmosphere.